🧬

Biyoteknoloji Sektörü Hisseleri

Biyoteknoloji Sektörü altında 614 Hisse Senedi

Biyoteknoloji sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.

Biyoteknoloji Sektörü Hakkında

Biyoteknoloji sektörü, genetik mühendisliği, ilaç geliştirme ve tıbbi araştırma alanında faaliyet gösteren şirketleri kapsar. Yüksek AR-GE yatırımları ve uzun geliştirme süreçleri ile karakterize edilir.

Temel Özellikler

  • Yüksek AR-GE yatırımları
  • Uzun geliştirme süreçleri
  • Düzenleyici onay riskleri
  • Yüksek büyüme potansiyeli

Önemli Şirketler

ModernaGilead SciencesBiogenRegeneron
100
Toplam Hisse
$139.1B
Toplam Piyasa Değeri

Biyoteknoloji Sektörü Hisseleri

Sayfa 2/7 (Toplam: 614)
SEMBOLŞİRKETPİYASA DEĞERİFİYATDEĞİŞİM
RAREUltragenyx Pharmaceutical Inc.$2.50B$26.440.19%
IBRXImmunityBio, Inc.$2.39B$2.711.12%
APGEApogee Therapeutics, Inc.$2.36B$39.601.25%
WGSGeneDx Holdings Corp.$2.31B$80.903.26%
AGIOAgios Pharmaceuticals, Inc.$2.30B$39.660.65%
VIAVViavi Solutions Inc.$2.29B$10.250.29%
BEAMBeam Therapeutics Inc.$2.17B$21.542.43%
TWSTTwist Bioscience Corporation$2.15B$35.833.05%
HRMYHarmony Biosciences Holdings, Inc.$2.11B$36.694.09%
IRONDisc Medicine, Inc.$2.10B$60.742.29%
ARWRArrowhead Pharmaceuticals, Inc.$2.07B$14.961.70%
VICRVicor Corporation$2.04B$45.205.44%
COGTCogent Biosciences, Inc.$2.04B$12.451.22%
ACHCAcadia Healthcare Company, Inc.$2.03B$22.041.85%
INDVIndivior PLC$2.02B$16.183.72%
DNLIDenali Therapeutics Inc.$2.01B$13.870.29%
VYXNCR Voyix Corporation$1.99B$14.432.01%
CGONCG Oncology, Inc. Common stock$1.98B$26.013.29%
BLTEBelite Bio, Inc$1.94B$59.672.65%
IDYAIDEAYA Biosciences, Inc.$1.93B$22.020.96%
FOLDAmicus Therapeutics, Inc.$1.92B$6.222.81%
VCELVericel Corporation$1.91B$37.987.11%
VSATViasat, Inc.$1.90B$14.601.42%
VCYTVeracyte, Inc.$1.84B$23.512.08%
OCULOcular Therapeutix, Inc.$1.84B$11.550.30%
SUPNSupernus Pharmaceuticals, Inc.$1.83B$32.671.69%
BCRXBioCryst Pharmaceuticals, Inc.$1.81B$8.651.53%
TARSTarsus Pharmaceuticals, Inc.$1.78B$42.340.38%
ARQTArcutis Biotherapeutics, Inc.$1.73B$14.551.46%
SPRYARS Pharmaceuticals, Inc.$1.73B$17.591.46%
SDGRSchrödinger, Inc.$1.67B$22.770.22%
TXG10x Genomics, Inc.$1.62B$12.9912.56%
ADPTAdaptive Biotechnologies Corporation$1.60B$10.532.13%
JANXJanux Therapeutics, Inc.$1.56B$26.381.15%
AZTAAzenta, Inc.$1.51B$32.925.11%
CLDXCelldex Therapeutics, Inc.$1.48B$22.361.36%
ETNB89bio, Inc.$1.46B$9.981.29%
ANIPANI Pharmaceuticals, Inc.$1.44B$66.341.42%
AORTArtivion, Inc.$1.43B$30.400.78%
VERAVera Therapeutics, Inc.$1.42B$22.292.19%
LQDALiquidia Corporation$1.42B$16.609.93%
UPBDUpbound Group, Inc.$1.40B$24.252.62%
NTLAIntellia Therapeutics, Inc.$1.40B$13.496.81%
TVTXTravere Therapeutics, Inc.$1.39B$15.661.01%
VRDNViridian Therapeutics, Inc.$1.38B$16.961.01%
BHVNBiohaven Ltd.$1.37B$13.432.75%
DVAXDynavax Technologies Corporation$1.34B$11.182.19%
VRNTVerint Systems Inc.$1.34B$22.273.10%
SRPTSarepta Therapeutics, Inc.$1.34B$13.622.21%
GRALGRAIL, Inc.$1.34B$37.168.18%
HROWHarrow Health, Inc.$1.33B$36.112.62%
DYNDyne Therapeutics, Inc.$1.30B$9.210.44%
WBTNWEBTOON Entertainment Inc. Common stock$1.30B$9.982.67%
ELVNEnliven Therapeutics, Inc.$1.27B$21.561.42%
VECOVeeco Instruments Inc.$1.26B$21.021.59%
INVAInnoviva, Inc.$1.21B$19.281.13%
MNKDMannKind Corporation$1.19B$3.932.88%
NVAXNovavax, Inc.$1.17B$7.220.70%
USPHU.S. Physical Therapy, Inc.$1.14B$75.030.12%
PRAXPraxis Precision Medicines, Inc.$1.13B$55.410.45%
SANASana Biotechnology, Inc.$1.10B$4.879.68%
OPKOPKO Health, Inc.$1.09B$1.381.43%
ARDXArdelyx, Inc.$1.06B$4.420.11%
GPCRStructure Therapeutics Inc.$1.05B$18.190.33%
IOVAIovance Biotherapeutics, Inc.$1.05B$3.1325.70%
YEXTYext, Inc.$1.04B$8.522.28%
PCRXPacira BioSciences, Inc.$1.04B$22.431.17%
BLFSBioLife Solutions, Inc.$1.02B$21.413.13%
PLSEPulse Biosciences, Inc.$1.02B$15.161.27%
COLLCollegium Pharmaceutical, Inc.$1.02B$31.642.36%
GLYCGlycoMimetics, Inc.$1.01B$15.712.76%
AKBAAkebia Therapeutics, Inc.$1.01B$3.850.26%
AMPHAmphastar Pharmaceuticals, Inc.$1.01B$21.350.76%
MDXGMiMedx Group, Inc.$998.47M$6.761.65%
SYRESpyre Therapeutics, Inc.$995.23M$16.490.86%
VERVVerve Therapeutics, Inc.$987.71M$11.081.37%
RCUSArcus Biosciences, Inc.$969.91M$9.161.08%
IMNMImmunome, Inc.$963.23M$11.072.31%
AVXLAnavex Life Sciences Corp.$954.10M$11.170.09%
ORICORIC Pharmaceuticals, Inc.$950.25M$11.150.81%
IARTIntegra LifeSciences Holdings Corporation$936.43M$12.055.98%
LENZLENZ Therapeutics, Inc.$928.26M$32.981.79%
PROKProKidney Corp.$896.60M$3.055.28%
SNDXSyndax Pharmaceuticals, Inc.$887.15M$10.315.96%
MLYSMineralys Therapeutics, Inc.$869.44M$13.342.06%
NRIXNurix Therapeutics, Inc.$860.06M$11.250.00%
SIONSionna Therapeutics, Inc.$839.25M$19.029.06%
TRVITrevi Therapeutics, Inc.$834.01M$7.002.64%
CRMDCorMedix Inc.$823.19M$11.061.10%
XERSXeris Biopharma Holdings, Inc.$819.99M$5.120.39%
GERNGeron Corporation$815.26M$1.284.07%
NUVBNuvation Bio Inc.$797.27M$2.350.21%
VIRVir Biotechnology, Inc.$792.10M$5.733.80%
AVBPArriVent BioPharma, Inc. Common Stock$791.15M$21.560.05%
KALVKalVista Pharmaceuticals, Inc.$789.77M$15.811.61%
URGNUroGen Pharma Ltd.$783.57M$16.969.70%
DNAGinkgo Bioworks Holdings, Inc.$781.40M$13.3517.93%
ANABAnaptysBio, Inc.$770.06M$26.210.15%
NAGENiagen Bioscience Inc$744.37M$9.452.38%
MAZEMaze Therapeutics, Inc.$741.92M$16.941.68%
ÖncekiSayfa 2 / 7Sonraki